A new chemoimmunotherapy regimen (OXAFI) for advanced hepatocellular carcinoma

A new chemoimmunotherapy regimen (OXAFI) for advanced hepatocellular carcinoma

BACKGROUND: Chemotherapeutic treatment options for advanced unresectable and/or metastatic hepatocellular carcinoma (Hcc) are limited. currently available treatments are associated with low response rates and little evidence of improved survival, so we evaluated a new chemoimmunotherapy regimen. MET...

Full description

Bibliographic Details
Main Authors: Mei-Kim Ang, Donald Poon, Kian-Fong Foo, Yaw-Fui Chung, Pierce Chow, Wei-Keat Wan, Choon-Hua Thng, London Ooi
Format: Article
Language:English
Published: Elsevier 2008-07-01
Series:Hematology/Oncology and Stem Cell Therapy
Online Access:http://www.sciencedirect.com/science/article/pii/S1658387608500240

Internet

http://www.sciencedirect.com/science/article/pii/S1658387608500240

Similar Items